Company intelligence / Profile preview
East India Pharmaceutical Works
Kolkata, West Bengal, Indiaeastindiapharma.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
East India Pharmaceutical Works markets over 100 pharmaceutical and some ayurvedic products, with its primary brands (such as Enteroquinol—an amoebicidal, Tonoferon—haematinic, Vitazyme—digestive enzyme, and Pyrigesic—analgesic) making up 85-90% of sales. The company maintains WHO-GMP-certified manufacturing plants; most business is in mature/generic products, and top-line revenues reached Rs. 249 crore in FY2024, with stable demand and moderate margins due to industry competitiveness and regulatory price caps[1][2].
- Therapeutic areas
- HematologyNeurologyInfectious DiseasesGastroenterologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on East India Pharmaceutical Works.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on East India Pharmaceutical Works.